BBlogFlow

How Maple Leafs' Nick Paul is doing his part for mental health - Toronto Sun

·6d ago
Source: Toronto Sun
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Skip to Content Subscribe FAQ My Account News Toronto & GTA Ontario Canada World Crime True Crime Weird Money Technology Tech Essentials Gaming Gadgets Weather Podcasts Opinion Editorials Columnists Editorial Cartoons Letters Send Letter to the Editor Sports Hockey PWHL Toronto Maple Leafs NHL Soccer Toronto FC MLS Baseball Toronto Blue Jays MLB Basketball Toronto Raptors NBA WNBA Football Toronto Argonauts CFL NFL Golf Other Sports Olympics Curling Tennis Horse Racing Wrestling Entertainment Celebrity Movies Music Television TV Listings Life Eat Fashion & Beauty Relationships Advice Sex Files Health Healthing Diet & Fitness Homes Travel Travel International Travel USA Travel Canada Ontario Travel Travel Essentials Contests Lives Told Tails Told Shopping Savings Toronto Sun Store Driving Vehicle Research Reviews News Gear Guide Obituaries Place an Obituary Place an In Memoriam Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place an Ad Business Card Directory Celebrations Working Business Ads This Week's Flyers ePaper SUNShine Girls Become a Sunshine Girl Puzzmo Diversions Comics Puzzles Horoscopes Newsletters Manage Print

This article is an excerpt. To read the full content, visit the original source. Toronto Sun

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·